Advances in HT-SPR, scBCR-seq and RNA-seq

There has been an increasing trend in developing unit operations that can be utilised in a continuous fashion, although fully continuous end-to-end operations

The remarkable rise of CRISPR genome editing technology was highlighted recently with the award of the 2020 Nobel Prize in Chemistry. While this transformational technology has countless applications in basic research, agbiotech, synthetic biology, and many other fields, most attention is currently focused on its clinical potential.

As the biologics market continues to grow and the industry focuses on identifying novel targets and mechanisms to generate more effective therapeutics, biological pipelines are evolving from standard

For most of humanity’s existence, we had only one way to make babies. The last century or so have seen the beginnings of change, with artificial insemination, in vitro fertilization, and prenatal and preimplantation genetic testing. The rest of this century will see astonishing changes, made both possible and attractive by genomics – from embryo selection to embryo editing, from mitochondrial transfer to human reproductive cloning, to in vitro gametogenesis, and beyond. This talk will survey those changes and point out some of their likely ethical, legal, and social implications.